In addition, one well-conducted study first proved CD8+ T cells could induce the ferroptosis in cancer cells via downregulating the SLC7A11 transcription and concomitant use of immune checkpoint inhibitors could synergistically enhance the anti-cancer capacity (Wang et al., 2019). This evidence concerns the gene SLC7A11 and cancer.